TY  - CONF
AU  - Fasching, P. A.
AU  - Bardia, A.
AU  - Nusch, A.
AU  - Jerusalem, G.
AU  - Chan, A.
AU  - El Saghir, N.
AU  - Alba, E.
AU  - Im, S-A.
AU  - Janni, W.
AU  - Chandiwana, D.
AU  - Lanoue, B.
AU  - Thuerigen, A.
AU  - Gaur, A.
AU  - Harbeck, N.
PY  - 2020
DO  - 10.1016/j.annonc.2020.08.378
SN  - 0923-7534
UR  - https://hdl.handle.net/10668/26855
T2  - Annals of oncology
LA  - en
PB  - Elsevier
TI  - Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2,-3, and-7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptore-positive, HER2-negative (HR+/HER2L) advanced breast cancer (ABC)
TY  - conference output
VL  - 31
ER  -